A double‐blind placebo‐controlled trial of tanakan in the treatment of idiopathic cognitive impairment in the elderly
The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
Fifty‐four elderly patients, living at home, completed a 3‐month, double‐blind, randomized, placebo‐controlled trial of the effects of Tanakan on both cognitive efficiency and the quality of life. Patients were included in the study if they showed mild signs of impairment in everyday function on the Crichton Geriatric Rating Scale. Cognitive efficiency was measured before and at monthly intervals during the trial using a battery of tests of mental ability comprising both computerized and pencil‐and‐paper tasks. The quality of life was assessed using a behavioural questionnaire which was administered before and after the study. Individual analyses of the cognitive tests showed some advantage of Tanakan over placebo, but when the accuracy scores from all eight tests were combined using two different techniques, although both groups improved over time, the improvement with Tanakan at week 12 was significantly greater than with placebo. No signs of improvement were detected with placebo when the reaction time measures were combined using these techniques, whereas by week 4 the Tanakan group were significantly faster than at baseline, and were superior to placebo throughout the study. These improvements in mental efficiency were accompanied by a significant increase in the interest taken in everyday activities, and suggest that the drug might be helpful in treating the early stages of primary degenerative dementia.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
. Cerebral blood flow in dementia.
Hachinski, V. C., Iliff, L. D., Zilhka, E., Du Boulay, G. H., McAllister, V. L., Marshall, J., Russell, R. W. R., & Symon, L. (1975) · Archives of Neurology · doi:10.1001/archneur.1975.00490510088009 · Cited by 3,186
Cited by
Doody, R. S., Stevens, J. C., Beck, C., Dubinsky, R. M., Kaye, J. A., Gwyther, L., Mohs, R. C., Thal, L. J., Whitehouse, P. J., DeKosky, S. T., et al. (2001) · Neurology · doi:10.1212/wnl.56.9.1154 · Cited by 1,720
The Efficacy of Ginkgo biloba on Cognitive Function in Alzheimer Disease
Oken, B. S., Storzbach, D. M., & Kaye, J. A. (1998) · Archives of Neurology · doi:10.1001/archneur.55.11.1409 · Cited by 585
Ginkgo biloba for cognitive impairment and dementia
Birks, J., & Grimley Evans, J. (2009) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003120.pub3 · Cited by 581
Kleijnen, J., & Knipschild, P. (1992) · The Lancet · doi:10.1016/0140-6736(92)93158-j · Cited by 461
Ginkgo biloba extract: Mechanisms and clinical indications
Diamond, B. J., Shiflett, S. C., Feiwel, N., Matheis, R. J., Noskin, O., Richards, J. A., & Schoenberger, N. E. (2000) · Archives of Physical Medicine and Rehabilitation · doi:10.1016/s0003-9993(00)90052-2 · Cited by 389
Metadata
- Authors
- Wesnes, K., Simmons, D., Rook, M., & Simpson, P.
- Venue
- Human Psychopharmacology: Clinical and Experimental
- Publisher
- Wiley
- Published
- 1987-09
- Volume
- 2
- Issue
- 3
- Pages
- 159-169
- ISSN
- 0885-6222 (ISSN-L)
- 1099-1077
- OpenAlex
- W2145662100
- Cited by
- 98
- References
- 1
- FWCI
- 0.74
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: A double‐blind placebo‐controlled trial of tanakan in the treatment of idiopathic cognitive impairment in the elderly. https://app.cochat.ai/papers/10.1002/hup.470020305
- The paper
- Wesnes, K., Simmons, D., Rook, M., & Simpson, P. (1987). A double‐blind placebo‐controlled trial of tanakan in the treatment of idiopathic cognitive impairment in the elderly. Human Psychopharmacology: Clinical and Experimental. https://doi.org/10.1002/hup.470020305
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.